Business Context and Reporting Period
Company: Inter Parfums, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2001
Business Overview: Inter Parfums is a global provider of prestige perfumes and mass market perfumes, cosmetics, and health and beauty aids. The company operates through a portfolio of licensed and owned brands, including Burberry, S.T. Dupont, Paul Smith, Christian Lacroix, Celine, and FUBU for prestige products, and Aziza and Intimate for mass market products. Operations are headquartered in New York and Paris.
Key Financial Metrics (Year Ended Dec 31, 2001)
| Metric | 2001 | 2000 |
|---|---|---|
| Net Sales | $112.2 million | $101.6 million |
| Gross Margin | $54.3 million (48.4%) | $49.7 million (48.9%) |
| Net Income | $8.1 million | $6.6 million |
| Diluted EPS | $0.41 | $0.34 |
| Cash & Equivalents | $28.6 million | $27.6 million |
| Working Capital | $68.2 million | $57.7 million |
| Long-Term Debt | $1.4 million | $1.4 million |
| Operating Cash Flow | $7.0 million | $0.2 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.5% to a record $112.2 million. On a constant currency basis, sales rose 12%. Growth was driven by a 13% increase in prestige products (led by Burberry Touch and Paul Smith) and a 5% increase in mass market products.
- Profitability: Net income increased 23% to $8.1 million. Diluted earnings per share rose 20% to $0.41.
- Margin Stability: Gross profit margins remained stable at 48.4%, slightly down from 48.9% in 2000, supported by a strong U.S. dollar against the Euro.
- Expense Management: Selling, General, and Administrative (SG&A) expenses increased to $39.6 million but declined as a percentage of sales to 35% from 37% in 2000 due to operating leverage.
- Cash Flow: Operating cash flow improved significantly to $7.0 million from $0.2 million in 2000, as inventory buildup from the prior year's launches normalized.
Guidance, Outlook, and Risks
Outlook and New Products
Management anticipates continued growth in 2002 driven by a strong pipeline of new product launches, including FUBU Plush, Burberry Baby Touch, Bazar from Christian Lacroix, and a Celine bath line. The company is also pursuing a potential acquisition of mass market fragrance brands from Tristar Corporation (subject to bankruptcy court approval) for approximately $10 million.
Risks and Contingencies
- Legal Proceedings: The company is involved in ongoing litigation with Jean Charles Brosseau regarding the Ombre Rose trademark. A $600,000 charge was taken in 2000, and an additional $142,000 advance payment was made in 2001. Management does not expect further material adverse effects.
- Tax Audits: The French subsidiary is subject to tax audits with assessments of $2.3 million. The company has reserved $760,000 and contests the majority of the assessments.
- Concentration Risk: Net sales of Burberry products accounted for 40.8% of total net sales in 2001.
- Market Risks: The company faces exposure to foreign currency fluctuations (hedging program in place) and intense competition in both prestige and mass markets.
Investor Verification Checklist
- Burberry Dependency: Verify the stability of the Burberry license agreement, which represents over 40% of revenue.
- Tristar Acquisition: Monitor the status of the proposed $10 million asset purchase from Tristar Corporation and its impact on mass market market share.
- Legal Exposure: Track the resolution of the Brosseau litigation and French tax audits to ensure no additional material charges are required.
- Currency Hedging: Assess the effectiveness of the hedging program given the volatility between the Euro and the U.S. dollar.
- Dividend Policy: Note the authorization of the first cash dividend ($0.06 per share) and the requirement for unanimous board approval for dividends exceeding 30% of net income.